Curevac Vaccine Approval Date. The company pulled the plug after determining that it might take until June for regulators to make a ruling about the vaccine. All COVID-19 vaccines approved in the EU have a positive.
In the fight against the coronavirus pandemic the Tübingen-based biotech company Curevac intends to start mass phase III tests before the end of the year. CureVac CVnCoV vaccine Start of rolling review. By June it had received regulatory approval to begin clinical trials.
CureVac receives a grant of up to 252 million euros from the German Federal Ministry of Education and Research to further its COVID-19 vaccine development and expand its production capacity.
Dry coughs can be heard everywhere complaints of aching muscles and tiredness increase and germs are. But despite the companys confidence its unclear whether the full results disclosed Wednesday will be enough to secure regulatory approval. Three vaccines under rolling review at the EMA. CureVac receives a grant of up to 252 million euros from the German Federal Ministry of Education and Research to further its COVID-19 vaccine development and expand its production capacity.
